86.90.A - Physiotherapeutical activities
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
47.99.Z - Other retail sale not in stores, stalls or markets
68.20.Z - Rental and operating of own or leased real estate
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,1 | -0 | 0 | 210,6 |
EBITDA | 0,3 | 0,4 | 0,4 | 24,7 |
Short time liabilities | 0,1 | 0,3 | 0,2 | -22,4 |
Equity capital | 0,6 | 0,5 | 0,6 | 3,3 |
Operating profit (EBIT) | 0,1 | 0,1 | 0,2 | 39,5 |
Assets | 2,7 | 2,7 | 2,5 | -8,8 |
Net profit (loss) | 0 | -0 | 0 | 204,7 |
Cash | 0,1 | 0,1 | 0,2 | 71,2 |
Net income from sale | 1,4 | 1,5 | 1,5 | 0,1 |
Liabilities and provisions for liabilities | 2,1 | 2,2 | 1,9 | -11,8 |
Working assets | 0,1 | 0,2 | 0,2 | 10 |
Depreciation | 0,2 | 0,2 | 0,3 | 16,1 |
% | % | % | p.p. | |
Profitability of capital | 8,8 | -3,1 | 3,2 | 6,3 |
Equity capital to total assets | 20,9 | 20 | 22,7 | 2,7 |
Gross profit margin | 3,6 | -1,2 | 1,3 | 2,5 |
EBITDA Margin | 20,7 | 24 | 29,9 | 5,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 37 | 69 | 53 | -16 |
Current financial liquidity indicator | 0.12725111842155457 | 0.26299652457237244 | 0.4025742709636688 | 0,1 |
Net dept to EBITDA | 5.056119918823242 | 4.52423095703125 | 3.2601494789123535 | -1,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane